Meningioma

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

ITM11 Expanded Access Program

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

MiDura-Study (Neuro-Patch in Duraplasty)

Abemaciclib in Newly Diagnosed Meningioma Patients

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

Plasma Extracellular Vesicles in Meningioma Patients

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Measurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Therapeutic Trial Using Radioligand Therapy (RLT)

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features